We rank companies based on fund manager, research analyst and news sentiment
ZURA stock icon

Zura Bio
ZURA

$3.31
10.3%
 

About: Zura Bio Ltd is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders.

Employees: 15

0
Funds holding %
of 6,474 funds
Analysts bullish %
0
News positive %
of 3 articles

Fund manager confidence

Based on 2023 Q4 SEC filings by fund managers ($100M+ AUM)

700% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 3

43% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 7

7% more funds holding

Funds holding: 41 [Q3] → 44 (+3) [Q4]

2.38% more ownership

Funds ownership: 32.44% [Q3] → 34.82% (+2.38%) [Q4]

24% less capital invested

Capital invested by funds: $93.3M [Q3] → $70.7M (-$22.6M) [Q4]

100% less funds holding in top 10

Funds holding in top 10: 1 [Q3] → 0 (-1) [Q4]

Research analyst outlook

1 Wall Street Analyst provided 1 year price forecasts over the past 6 months

Low target
$16
383%
upside
Avg. target
$16
383%
upside
High target
$16
383%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
Oppenheimer
Jeff Jones
383%upside
$16
Outperform
Reiterated
1 Apr 2024

Financial journalist opinion

Based on 3 articles about ZURA published over the past 30 days